1Cademy - Discussion from Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Learn Before

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Concept

Discussion from Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

There were no significant differences observed between the study outcomes among the intervention versus control arms. This study was unable to determine any benefit of HCQ treatment to outpatients with mild COVID-19 beyond usual care.

Updated 2020-08-06

Contributors are:

Ashley Murphy

🏆 1

Who are from:

University of Michigan - Ann Arbor

🏆 1

References

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Learn After

Study Limitations from Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Learn Before

Related

Learn After